IM-862 in Treating Patients With Recurrent Ovarian Cancer
NCT00003773
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
oglufanide disodium
Sponsor
University of Southern California
Collaborators
[object Object]